top of page

High-Temperature Insulation in Pharmaceutical Plants: How Aerogel Reduces Energy Loss by Up to 60%

ree

In Switzerland and Germany—home to some of the world’s most advanced pharmaceutical manufacturers—energy performance is now a competitive advantage. Steam networks, sterilizers, reactors, CIP/SIP systems, dryers and high-temperature process lines all consume significant energy. As EU and national energy requirements tighten and carbon-reduction targets accelerate, plants are reassessing where meaningful savings can be made without risking product quality or GMP compliance. One of the most effective levers is thermal insulation. In this context, aerogel insulation is rapidly becoming the material of choice thanks to its ultra-low thermal conductivity, thin profile, and durability in demanding environments.


This article explains how aerogel works, where it outperforms traditional materials, and how pharmaceutical facilities can realize up to 60% lower heat loss on critical assets—often with attractive payback periods and improved reliability.


Why High-Temperature Insulation Matters in Pharma


Pharmaceutical manufacturing relies on precise temperature control and hygienic operations. Poorly insulated assets lead to:


  • Excess heat loss from steam distribution, sterilizers, reactors and process vessels

  • Unstable process conditions, impacting batch consistency and cycle times

  • Higher utility spend and difficulty meeting ISO 50001 energy targets

  • Safety risks from hot surfaces and inconsistent ambient temperatures

  • Hidden integrity issues like corrosion under insulation (CUI)


Insulation is therefore both a quality and performance measure. With the right material choice, plants can reduce energy consumption while improving operational stability and compliance readiness.


What Makes Aerogel Different?


Aerogel is a silica-based nanomaterial composed of up to ~99% air, with a highly porous microstructure that suppresses conductive, convective and radiative heat transfer. Typical thermal conductivity (lambda) values for industrial aerogel blankets are ~0.013–0.018 W/m·K, markedly lower than conventional materials such as mineral wool or calcium silicate (~0.035–0.045 W/m·K).


Key properties for pharmaceutical environments:


  • High thermal performance in thin layers: comparable (or better) insulation with up to 50% less thickness—critical in congested utilities corridors

  • Hydrophobic and breathable: helps minimize moisture ingress that can drive CUI on carbon-steel assets

  • Flexible, conformable blankets: easier to install on valves, tees and complex geometries, reducing thermal bridges

  • High temperature stability: suitable for steam and high-temperature process lines

  • Cleanability/encapsulation options: can be jacketed for clean-room adjacency and fiber containment where required by site SOPs

Aerogel vs. Traditional Insulation (At a Glance)

Attribute

Traditional Insulation (Mineral Wool/Calcium Silicate)

Aerogel Insulation

Thermal conductivity (W/m·K)

~0.035–0.045

~0.013–0.018

Thickness for same performance

100%

~50%

Moisture uptake risk

Moderate–High

Low (hydrophobic)

CUI risk over time

Elevated

Significantly reduced

Flexibility on complex assets

Limited

High (blankets)

Typical service life

5–7 years

10–15+ years

Lifecycle cost (10 years)

Baseline

~30–40% lower

Values represent typical ranges; actual performance depends on design, installation quality, and operating conditions.


Where Aerogel Delivers the Biggest Impact in Pharma


  • Steam distribution & condensate return (utility rooms to production suites)

  • Sterilizers/Autoclaves (exterior hot surfaces and connected piping)

  • Reactors & process vessels (batch temperature stability)

  • Dryers and ovens (reduced heat loss, safer surfaces)

  • CIP/SIP skids and manifolds (complex geometry, frequent thermal cycling)

  • Heat exchangers & hot oil systems (thin-profile cladding in tight spaces)


In these applications, field data from retrofits commonly show double-digit percentage reductions in heat loss compared with legacy insulation—and, in optimized projects, up to 60% depending on baseline condition and geometry.


Quantifying Energy Savings: A Simple Framework


  1. Audit the baseline: measure surface temperatures, line sizes, media temperatures and hours of operation. Identify missing/damaged insulation.

  2. Model heat loss: use standardized calculations to estimate current losses (W/m) vs. proposed aerogel thickness.

  3. Prioritize by ROI: rank assets by annual kWh/€ savings and accessibility for installation.

  4. Implement in waves: start with steam mains, high-differential lines, and the worst-performing sections.

  5. Verify: post-install IR scans and meter data to confirm savings and adjust maintenance plans.


Because thinner aerogel achieves target surface temperatures with less bulk, projects often avoid clashes with pipe racks and accessways, cutting redesign time and installation hours.


Safety, Quality, and Compliance Considerations


  • GMP & cleanability: Aerogel blankets can be encapsulated with cleanable jacketing to meet site hygiene and fiber-control requirements near clean areas. Engineering controls and SOPs govern where insulation is exposed vs. jacketed.

  • Worker safety: Better insulation reduces burn risk and helps maintain safer ambient conditions for operators and maintenance teams.

  • CUI prevention: Hydrophobic aerogel reduces water retention at the metal/insulation interface, helping mitigate corrosion mechanisms. Pair with proper vapor barriers and jacketing.

  • Energy management: Documented savings support ISO 50001 objectives and corporate ESG reporting.


Case Snapshot (Illustrative): Basel Sterilization Suite Retrofit


A Swiss facility serving sterile manufacturing modernized 250 m of steam and hot-water lines feeding autoclaves and process vessels. The project replaced mixed, aged mineral wool with aerogel blankets and added jackets on all valves and tees.


12-month results:

  • Heat loss reduction: ~48% average across measured segments; peak reductions near complex valve stations

  • Energy savings: ~17% drop in steam consumption for targeted assets

  • Maintenance: fewer hot spots; simplified access due to thinner profile

  • Safety: surface temperatures reduced to below site limits without increasing insulation thickness beyond clearance constraints


Note: Results vary by baseline condition, media temperature, ambient environment and installation quality.


Lifecycle Cost & Payback


Although aerogel materials typically carry a higher unit cost, total economics are favorable when factoring installation, performance and longevity.

Cost Driver (10-year view)

Traditional

Aerogel

Material & labor (initial)

Low–Moderate

Moderate

Installation duration

Longer (rigid forms)

Shorter (conformable blankets)

Energy cost (losses)

Higher

Lower

Maintenance & replacements

Frequent

Infrequent

Unplanned downtime risk

Elevated (CUI/hot spots)

Reduced

Total Cost of Ownership

Baseline

~25–40% lower

Payback periods of 18–24 months are common where operating hours are high and baseline insulation is degraded or oversized.


Implementation Roadmap for Pharma Sites


  1. Screening study: identify heat-intensive users and critical GMP-adjacent areas

  2. Thermography walkdown: locate hot spots and missing insulation

  3. Engineering & specification: define aerogel thicknesses, jacketing, labeling, and QA checks

  4. Pilot section: validate constructability, surface temps and cleanability

  5. Rollout: schedule during planned maintenance windows to minimize impact

  6. Monitoring: add simple temperature tags or sensors for continuous improvement


Why Partner with Aerohik


Aerohik (Switzerland) designs and supplies aerogel-based high-temperature insulation systems tailored to regulated industries. Our teams support:


  • Application engineering and thickness selection

  • Hygienic jacketing and enclosure design for clean-room adjacency

  • Installation planning for complex geometries (valves, flanges, manifolds)

  • Post-install verification (IR scans, surface temperature mapping)


With Swiss precision and proven aerogel technology, Aerohik helps pharmaceutical facilities achieve measurable energy savings, safer work environments, and long-lived insulation performance.


Frequently Asked Questions (FAQ)


Q1: Is aerogel suitable near clean-room areas?Yes—when properly jacketed/encapsulated per site SOPs. Many sites use smooth, cleanable cladding to control particle release and support hygienic standards.

Q2: What temperature ranges can aerogel handle?Industrial-grade aerogel blankets are designed for high-temperature service common to steam and hot oil lines. Final selection depends on process conditions and safety margins.

Q3: Can we realize 60% energy-loss reduction everywhere?“Up to 60%” reflects best-case improvements on poorly insulated or complex assets. Typical projects deliver strong double-digit savings; precise results depend on baseline and design.

Q4: How does aerogel impact CUI risk?Aerogel’s hydrophobic structure, combined with correct jacketing and vapor barriers, reduces moisture residence time, helping mitigate CUI mechanisms.


Conclusion


For pharmaceutical manufacturers in Switzerland, Germany and across Europe, aerogel insulation offers a practical path to substantial energy savings, safer operations and predictable lifecycle costs—without compromising GMP expectations. By targeting high-temperature assets with thin, high-performance aerogel blankets—and validating results with thermography—plants can unlock meaningful, verifiable reductions in heat loss, often achieving payback in under two years.


 
 
 

Comments


bottom of page